Immuno-oncology is reshaping cancer treatment by harnessing the body’s immune system to target cancer cells.
This area of research acts on the immune system rather than the cancer directly, creating the potential for a single medicine to be used to treat multiple cancer types.
ME Therapeutics is advancing a pipeline of therapeutic programs that reprogram immune cells in vivo to directly recognize cancer cells and activate the body’s immune response against cancer.
We are a team of scientists who believe in the power of the immune system to transform how cancer is treated.
